Observational registry of patients with diabetes and hormone or metabolic disorders
Records clinical data from patients with diabetes and metabolic or hormone disorders over time.
Plain-language title generated from the registry record
Registry title: Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders
Key facts
- Where
- Milan, ItalySee the site
Where in Italy
- Diabetology Department, San Raffaele Scientific InstituteMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IRCCS San Raffaele
- Trial code
- NCT07206875
- Record updated
- 3 November 2026
- Original description
The main objective of this retrospective and prospective observational register is to identify anthropometric, clinical, laboratory and/or instrumental markers of disease severity and activity in patients suffering from diabetes, endocrine-metabolic disorders, rare diseases in order to improve their diagnosis, monitoring and treatment processes. The Registry is monocentric, observational prospective and retrospective. No additional procedures to those of normal clinical practice are planned, and neither diagnostic approaches nor experimental drugs/prescriptions will be applied. The data under study (demographic, anthropometric, clinical and care characteristics) will be collected as part of outpatient visits of the Diabetes Outpatient Clinic or admission to Diabetes Day Hospital.Read full original descriptionShow less
Retrospective and Prospective Observational Registry for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine-metabolic Disorders
The main objective of this retrospective and prospective observational register is to identify anthropometric, clinical, laboratory and/or instrumental markers of disease severity and activity in patients suffering from diabetes, endocrine-metabolic disorders, rare diseases in order to improve their diagnosis, monitoring and treatment processes. The Registry is monocentric, observational prospective and retrospective. No additional procedures to those of normal clinical practice are planned, and neither diagnostic approaches nor experimental drugs/prescriptions will be applied. The data under study (demographic, anthropometric, clinical and care characteristics) will be collected as part of outpatient visits of the Diabetes Outpatient Clinic or admission to Diabetes Day Hospital.
In case of outpatients, the observation will start at the diagnosis or during the first outpatient visit and will end with the last outpatient visit performed within the total time foreseen for the duration of the study.
The study will start once the regulatory authorizations are completed, and is expected to last at least 10 years with the possibility of extension
Inclusion: Age ≥18 years; Outpatient Diabetes Unit patient; Ability to give informed consent; Diagnosis of at least one of the following:; Metabolic disease, defined as BMI ≥25 Kg/m2; Type 1 or type 2 diabetes mellitus; Gestational diabetes; Monogenic diabetes (MODY); Other types of diabetes or dysglycemia; Dyslipidemia; Arterial hypertension; Steatosis liver disease (SLD).
Exclusion: Age <18 years; Deny participation at the study; Recruitment in an interventional protocol; Patients with missing significant data.